Position in EVO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$390,868
+$92,346 QoQ
Shares Held
139,596
+16.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 34 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $338,809,559 across 34 Drug Manufacturers - Specialty & Generic names. EVO ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,276,154 | $58,556,516 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,702,176 | $57,669,722 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
262,192 | $44,189,839 | |
| 4 | VTRS |
Viatris Inc
|
2,354,974 | $37,396,987 | |
| 5 | ZTS |
Zoetis Inc.
|
440,465 | $31,651,814 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,598,174 | $25,618,729 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
934,265 | $22,992,261 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
35,362 | $19,160,192 |
All Filings in EVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,868 | 139,596 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $298,522 | 119,409 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $215,698 | 70,032 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $274,830 | 75,711 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $384,988 | 91,664 | Shares | Sole | 2025-08-01 | |
| No filing history on record for this holder in this stock. | ||||||